Resultados de procura - Marianne M. Stanford

  • Mostrando 1 - 14 Resultados de 14
Limitar resultados
  1. 1
    Myxoma virus in the European rabbit: interactions between the virus and its susceptible host

    Myxoma virus in the European rabbit: interactions between the virus and its susceptible host por Marianne M. Stanford, Steven J. Werden, Grant McFadden

    Publicado 2007
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  2. 2
    Immunopathogenesis of poxvirus infections: forecasting the impending storm

    Immunopathogenesis of poxvirus infections: forecasting the impending storm por Marianne M. Stanford, Grant McFadden, Gunasegaran Karupiah, Geeta Chaudhri

    Publicado 2007
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  3. 3
    Oncolytic Virotherapy Synergism with Signaling Inhibitors: Rapamycin Increases Myxoma Virus Tropism for Human Tumor Cells

    Oncolytic Virotherapy Synergism with Signaling Inhibitors: Rapamycin Increases Myxoma Virus Tropism for Human Tumor Cells por Marianne M. Stanford, John W. Barrett, Steven H. Nazarian, Steven J. Werden, Grant McFadden

    Publicado 2006
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  4. 4
    Intravenously Administered Alphavirus Vector VA7 Eradicates Orthotopic Human Glioma Xenografts in Nude Mice

    Intravenously Administered Alphavirus Vector VA7 Eradicates Orthotopic Human Glioma Xenografts in Nude Mice por Jari Heikkilä, Markus Vähä‐Koskela, Janne Ruotsalainen, Miika Martikainen, Marianne M. Stanford, J. Andrea McCart, John C. Bell, Ari Hinkkanen

    Publicado 2010
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  5. 5
    Infection of human cancer cells with myxoma virus requires Akt activation via interaction with a viral ankyrin-repeat host range factor

    Infection of human cancer cells with myxoma virus requires Akt activation via interaction with a viral ankyrin-repeat host range factor por Gen Wang, John W. Barrett, Marianne M. Stanford, Steven J. Werden, James B. Johnston, Xiujuan Gao, Mei Sun, Jin Q. Cheng, Grant McFadden

    Publicado 2006
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  6. 6
    Targeting Human Medulloblastoma: Oncolytic Virotherapy with Myxoma Virus Is Enhanced by Rapamycin

    Targeting Human Medulloblastoma: Oncolytic Virotherapy with Myxoma Virus Is Enhanced by Rapamycin por Xue Qing Lun, Hongyuan Zhou, Tommy Alain, Beichen Sun, Limei Wang, John W. Barrett, Marianne M. Stanford, Grant McFadden, John C. Bell, Donna L. Senger, Peter Forsyth

    Publicado 2007
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  7. 7
    A Respiratory Syncytial Virus Vaccine Based on the Small Hydrophobic Protein Ectodomain Presented With a Novel Lipid-Based Formulation Is Highly Immunogenic and Safe in Adults: A First-in-Humans Study

    A Respiratory Syncytial Virus Vaccine Based on the Small Hydrophobic Protein Ectodomain Presented With a Novel Lipid-Based Formulation Is Highly Immunogenic and Safe in Adults: A F... por Joanne M. Langley, Lisa D. MacDonald, Genevieve Weir, Donna MacKinnon‐Cameron, Lingyun Ye, Shelly McNeil, Bert Schepens, Xavier Saelens, Marianne M. Stanford, Scott A. Halperin

    Publicado 2018
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  8. 8
    Myxoma Virus Oncolysis of Primary and Metastatic B16F10 Mouse Tumors In Vivo

    Myxoma Virus Oncolysis of Primary and Metastatic B16F10 Mouse Tumors In Vivo por Marianne M. Stanford, Mae Shaban, John W. Barrett, Steven J. Werden, Philippe-Alexandre Gilbert, Joe Bondy-Denomy, Lisa T. MacKenzie, Kevin C. Graham, Ann F. Chambers, Grant McFadden

    Publicado 2007
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  9. 9
    First-in-man application of a novel therapeutic cancer vaccine formulation with the capacity to induce multi-functional T cell responses in ovarian, breast and prostate cancer patients

    First-in-man application of a novel therapeutic cancer vaccine formulation with the capacity to induce multi-functional T cell responses in ovarian, breast and prostate cancer pati... por Neil L. Berinstein, Mohan Karkada, Michael A. Morse, John Nemunaitis, Gurkamal Chatta, Howard L. Kaufman, Kunle Odunsi, Rita Nigam, Leeladhar Sammatur, Lisa D. MacDonald, Genevieve Weir, Marianne M. Stanford, Marc Mansour

    Publicado 2012
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  10. 10
    Synergistic Interaction Between Oncolytic Viruses Augments Tumor Killing

    Synergistic Interaction Between Oncolytic Viruses Augments Tumor Killing por Fabrice Le Bœuf, Jean‐Simon Diallo, J. Andrea McCart, Steve H. Thorne, Theresa Falls, Marianne M. Stanford, Femina Kanji, Rebecca C. Auer, Chris W. Brown, Brian D. Lichty, Kelley A. Parato, Harold Atkins, David H. Kirn, John C. Bell

    Publicado 2010
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  11. 11
    ORFV: A Novel Oncolytic and Immune Stimulating Parapoxvirus Therapeutic

    ORFV: A Novel Oncolytic and Immune Stimulating Parapoxvirus Therapeutic por Julia L. Rintoul, Chantal G. Lemay, Lee‐Hwa Tai, Marianne M. Stanford, Theresa Falls, Christiano Tanese de Souza, Byram W. Bridle, Manijeh Daneshmand, Pamela S. Ohashi, Yonghong Wan, Brian D. Lichty, Andrew A. Mercer, Rebecca C. Auer, Harold Atkins, John C. Bell

    Publicado 2012
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  12. 12
    Enhancement of Vaccinia Virus Based Oncolysis with Histone Deacetylase Inhibitors

    Enhancement of Vaccinia Virus Based Oncolysis with Histone Deacetylase Inhibitors por Heather MacTavish, Jean‐Simon Diallo, Baocheng Huang, Marianne M. Stanford, Fabrice Le Bœuf, Naomi De Silva, Julie A. Cox, John-Graydon Simmons, Tanya Guimond, Theresa Falls, J. Andrea McCart, Harry Atkins, Caroline J. Breitbach, David H. Kirn, Stephen H. Thorne, John C. Bell

    Publicado 2010
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  13. 13
    Targeting Tumor Vasculature With an Oncolytic Virus

    Targeting Tumor Vasculature With an Oncolytic Virus por Caroline J. Breitbach, Naomi S. De Silva, Theresa Falls, Usaf E. Aladl, Laura Evgin, Jennifer M Paterson, Yang Sun, Dominic G. Roy, Julia L. Rintoul, Manijeh Daneshmand, Kelley A. Parato, Marianne M. Stanford, Brian D. Lichty, Aaron Fenster, David H. Kirn, Harold Atkins, John C. Bell

    Publicado 2011
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  14. 14
    Survivin-targeted immunotherapy drives robust polyfunctional T cell generation and differentiation in advanced ovarian cancer patients

    Survivin-targeted immunotherapy drives robust polyfunctional T cell generation and differentiation in advanced ovarian cancer patients por Neil L. Berinstein, Mohan Karkada, Amit M. Oza, Kunle Odunsi, Jeannine Villella, John Nemunaitis, Michael A. Morse, Tanja Pejović, J. Bentley, Marc Buyse, Rita Nigam, Genevieve Weir, Lisa D. MacDonald, Tara Quinton, Rajkannan Rajagopalan, Kendall Sharp, Andrea Penwell, Leeladhar Sammatur, Tomasz Burzykowski, Marianne M. Stanford, Marc Mansour

    Publicado 2015
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:

Ferramentas de procura: